Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens?
P. Kopinski, J. Szczeklik, J. Chorostowska-Wynimko, B. Balicka-Slusarczyk, A. Szpechcinski, G. Przybylski, A. Jarzemska, E. Polgesek (Bygoszcz-Torun, Krakow, Warszawa, Bydgoszcz-Torun, Poland)
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Session: Clinical issues in diffuse parenchymal lung disease
Session type: Thematic Poster Session
Number: 837
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kopinski, J. Szczeklik, J. Chorostowska-Wynimko, B. Balicka-Slusarczyk, A. Szpechcinski, G. Przybylski, A. Jarzemska, E. Polgesek (Bygoszcz-Torun, Krakow, Warszawa, Bydgoszcz-Torun, Poland). Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens?. Eur Respir J 2010; 36: Suppl. 54, 837
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006
Immunohistochemical analysis of T lymphocytes (TLs) in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) suggests potential role of CD8+ TLs in lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 46s Year: 2004
aE b7 integrin (CD103-b7 ) expression in bronchoalveolar T lymphocytes in interstitial lung diseasesSource: Eur Respir J 2007; 30: Suppl. 51, 576s Year: 2007
The role of macrophages in interstitial lung diseases Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017 Year: 2017
TNFα and INFγ inducing capacity of sera from interstitial lung diseases (ILD) patients in relation to its angiogenic activity Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001
Airway dendritic cell phenotypes in inflammatory diseases of the human lung Source: Eur Respir J 2007; 30: 878-886 Year: 2007
A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
Cytokine and chemokine release in response to Pseudomonas aeruginosa (PA), by bronchial epithelium of the native airway and transplanted lung of paediatric cystic fibrosis (CF) lung transplant recipients Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012
Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009
Subpopulation analysis of peripheral blood lymphocytes in different variants of exogenic allergic alveolitis (EAA) Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Dendritic cells and the immunological homeostasis of the lung Source: Annual Congress 2006 - A new look at dendritic cell interactions in the lung Year: 2006
Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis Source: Eur Respir J 2007; 30: 165-171 Year: 2007
Cytotoxic lymphocytes in different interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 226s Year: 2003
Phenotype of dendritic cells (DCs) stimulated by microbial antigens in COPD patients with frequent and infrequent exacerbations. Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Decreased small airway and alveolar mature dendritic cells in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
Dendritic cell subsets in the lung: implication for allergic asthma Source: Annual Congress 2006 - A new look at dendritic cell interactions in the lung Year: 2006
Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling. Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018